real-time news and commentary for investors
Thursday, Aug 22
Malinckrodt says the FDA has accepted its NDA for Pennsaid
- Mallinckrodt (MNK -0.5%) says the FDA has accepted for review its New Drug Application for Pennsaid, a non-steroidal anti-inflammatory drug used for treating the signs and symptoms of osteoarthritis of the knee.
- The agency expects to respond to the NDA by February 7, 2014.